Published in Cancer Weekly, March 23rd, 2004
Tumors in which the p53 gene is mutated respond less well to treatment. However, by adding another agent, researchers at the Institut Curie have succeeded in increasing the efficacy of chemotherapy in mice bearing human cancer xenografts.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.